Company* (Country; Symbol)

Company* (Country)

Type/Product Area

Terms/Details (Date)

Aastrom Biosciences Inc. (ASTM)

Corning Inc.

Exclusive sublicense agreement related to Aastrom's cell transfection technology for increased efficiency in loading genetic material into cells

Corning's Life Sciences business will use Aastrom's technology to enhance the development of its molecular and cell culture applications in areas that are not competitive to Aastrom's core business interests; Aastrom retains exclusive rights to the applications of the technology involving cells for therapeutic applications, and will receive up-front payments and potential royalties from Corning (12/12)

Accelrys Inc. (subsidiary of Pharmacopeia Inc.; PCOP)

Intervet Innovation GmbH (Germany)

Three-year software licensing agreement for Accelrys' molecular modeling, simulation and combinatorial chemistry applications

Agreement provides Intervet scientists access to Accelrys solutions ranging from protein simulation and virtual screening tools to structural diversity applications (11/11)

Affymetrix Inc. (AFFX)

Arcturus Engineering Inc.

Strategic relationship to link Affymetrix's microarray technology with the laser capture microdissection of Arcturus

Arcturus gains access to Affymetrix's standard and custom GeneChip brand arrays, instrumentation and software to monitor gene expression for use in discovery efforts to develop microgenomics array-based diagnostic products; Affymetrix made a $3M equity investment in Arcturus (12/9)

Endovasc Ltd. Inc. (OTC BB:ENVC)

Philip Morris

Agreement in which Philip Morris extended a grant for a one-year period to further study the potential for practical use of Endovasc's nicotine-based heart treatment, Angiogenix

Further details were not disclosed (11/6)

Helix BioMedix Inc. (Canada; TSE:HBP)

Nu Skin Enterprises Inc.

Development agreement to explore the use of a Helix peptide in a new acne treatment product

Helix will receive a technology access fee and royalties based on the performance of the peptide (11/8)

Meristem Therapeutics*(France)

Japan Tobacco (Japan)

Worldwide, commercial license agreement for Japan Tobacco's monocot transformation system, PureIntro

Financial terms were not disclosed (12/18**)

Proteome Systems Ltd.*(Australia)

Nestle (Switzerland)

Collaboration on a glycoproteomics program to analyze the sugars attached to proteins in milk

Proteome Systems will apply its platform of glycoproteomic analysis, GlycomIQ, to analyze the sugars on the milk proteins (12/10)

Notes:

# This chart does not include agreements that involve agricultural product development.

* Private companies are indicated with an asterisk.

** Denotes the date the item ran in BioWorld International.

Unless otherwise noted, the trading symbols listed for public companies are on the Nasdaq market.

OTC BB = Over the Counter Bulletin Board; TSE = Toronto Stock Exchange